Sign in

    Daniel Burton

    Chief Executive Officer at Health Catalyst Inc
    Board
    Since October 2012
    Age
    49 years
    Education
    Holds a Bachelor of Science degree from Brigham Young University and a Master of Business Administration from Harvard Business School.
    Tenure
    Joined HCAT as an adviser in January 2011, became a board member in September 2011, served as President from September 2011 to October 2012, and has been CEO since October 2012.

    Also at Health Catalyst Inc

    BL
    Benjamin Landry
    General Counsel and Corporate Secretary
    DL
    Dan LeSueur
    Chief Operating Officer
    JA
    Jason Alger
    Chief Financial Officer (CFO)

    About

    Daniel Burton has built a diverse professional background with significant leadership roles in technology and healthcare industries. His career includes founding a private investment firm, leading corporate strategy initiatives at a major technology company, and working in consulting roles at renowned firms.

    At HCAT, he began contributing as an adviser in January 2011 and quickly advanced to a board membership in September 2011, reflecting his valued expertise and leadership.

    In October 2012, he assumed the role of Chief Executive Officer, overseeing strategic direction and growth at the company. His journey at HCAT, marked by a rapid ascent through key positions, underlines his effective management and extensive industry experience.

    $HCAT Performance Under Daniel Burton

    Past Roles

    OrganizationRoleDate RangeDetails
    Health Catalyst (HCAT) President September 2011 - October 2012 N/A
    Health Catalyst (HCAT) Adviser January 2011 - September 2011 N/A
    HB Ventures, LLC Co-founder/Adviser N/A Co-founded this private investment firm prior to joining HCAT
    Micron Technology, Inc. Led Corporate Strategy Group N/A N/A
    HP Inc. (HPQ) Strategy and Marketing Management N/A Spent eight years in strategy and marketing management roles
    Boston Consulting Group Associate Consultant N/A Advised healthcare systems and technology companies

    Fixed Compensation

    Data from  FY 2023
    Component NameAmountPayment ScheduleAdditional Details
    Salary$0N/AVoluntarily reduced cash compensation by 100% from July 2022 through December 2023 due to cost reduction initiatives
    Option Awards$0N/ANo stock options were granted during 2023
    Stock Awards$0N/ADeclined equity grants including RSUs and PRSUs
    Nonequity Incentive Plan Compensation$0N/ADeclined receiving the cash portion of the annual bonus for 2023
    All Other Compensation$0N/ANo matching contributions under the 401(k) plan or other forms of compensation provided

    Performance Compensation

    Data from  FY 2023

    No information available on performance compensation for 2023